<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>EIN News: Central Asia Biotech News</title>
<link>http://www.einnews.com/central-asia/newsfeed-central-asia-biotech</link><description>Constantly updated news and information about world affairs.</description><item>
<title>DIARY - Western European Corporate events from July 25, 2008</title>
<link>http://www.einnews.com/news.php?wid=180194866</link>
<pubDate>25 Jul 2008 07:09 GMT</pubDate>
<description>
...  SDG SA Q2 &lt;GAS.MC&gt; 29/Jul ES Puleva Biotech SA H1 &lt;PUL.MC&gt; 29/Jul CH Also Holding  ...  Brothers Group PLC YRTRADE &lt;CBRO.L&gt; 30/Jul GB Kazakhmys PLC Q2 TRADE &lt;KAZ.L&gt; 30/Jul GB Lloyds  ...
</description>
</item><item>
<title>Clinical Trials in Russia. 2nd Quarter 2008</title>
<link>http://www.einnews.com/news.php?wid=180175650</link>
<pubDate>25 Jul 2008 04:47 GMT</pubDate>
<description>
...  trials for Russian and foreign pharmaceutical and biotechnological companies  from registration of the studies  ...  Moscow, Saint-Petersburg, Novosibirsk, Yekaterinburg, Perm and Almaty (Kazakhstan). The companys headquarters are in Moscow. ###  ...
</description>
</item><item>
<title>Syngenta Half Year Results 2008: Strong performance, positive outlook</title>
<link>http://www.einnews.com/news.php?wid=179991872</link>
<pubDate>24 Jul 2008 05:29 GMT</pubDate>
<description>
...  will capture a wide range of future biotech opportunities. The development of a fully traited  ...  rapid growth, notably in Russia, Ukraine and Kazakhstan. NAFTA saw good sales growth in a  ...
</description>
</item></channel>
</rss>
